Preparing for the Next Wave in Diabetes Care: Emerging Clinical Developments and Pharmacist Readiness

Meeting Objectives:

• • Review anticipated clinical and regulatory developments in diabetes therapy — including potential cardiovascular outcome trial (CVOT)-related label expansion — and their implications for pharmacy practice.  
  • Discuss how pharmacists can prepare for evolving treatment indications amid regulatory timing uncertainty, without dependency on a specific approval date.
  • Explore pharmacist decision-making around therapy selection and patient counseling as the diabetes treatment landscape continues to shift.